FRIBEVI
Live / Allowed — Publication / registration review complete (as of 01 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 04 Jun 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 79453072
- Mark type
- Stylized text
- Filed
- 04 Jun 2026
- Published for opposition
- 20 Oct 2026
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; chemical preparations for pharmaceutical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; Biological preparations for medical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; injectable pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; medicines for use in human for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases
Owner
Prosecution history
- 23 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Sept 2026 — ASSIGNED TO EXAMINER
- 09 Jul 2026 — APPLICATION FILING RECEIPT MAILED
- 09 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Jul 2026 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 25 Jun 2026 — SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB